Centre for Mental Health, Addiction and Suicide Research, University of Bristol, Bristol, UK.
Schizophr Res. 2013 Aug;148(1-3):87-92. doi: 10.1016/j.schres.2013.05.015. Epub 2013 Jun 6.
Low early life vitamin D status is associated with an increased risk of schizophrenia and psychotic experiences. Here we examine if maternal pregnancy vitamin D concentrations are associated with offspring psychotic experiences as young adults.
A community sample of 2047 participants was investigated. Maternal prenatal 25 hydroxyvitamin D (25(OH)D) concentrations were assessed with tandem mass spectroscopy. Psychotic experiences were assessed at age 18years using a semi-structured clinical interview.
177 cohort members reported suspected or definite psychotic experiences, There was no evidence of an association between maternal 25(OH)D concentrations as quartiles (p=0.85 hypothesis test of general association versus no association across the quartiles) or as a continuous variable (p=0.89) versus experience of suspected and definite psychotic experiences at 18years. Within the cohort, only 29 subjects met criteria for a psychotic disorder at age 18. Based on this sample, there was no significant association between maternal 25(OH)D and psychotic disorder at 18years.
Maternal vitamin D levels were not associated with risk of psychotic experiences nor psychotic disorders in this birth cohort.
低生命早期维生素 D 状态与精神分裂症和精神病体验风险增加有关。在这里,我们研究了母体妊娠维生素 D 浓度是否与后代成年早期的精神病体验有关。
对 2047 名参与者的社区样本进行了调查。采用串联质谱法检测母体产前 25 羟维生素 D(25(OH)D)浓度。使用半结构化临床访谈在 18 岁时评估精神病体验。
177 名队列成员报告了疑似或明确的精神病体验。母体 25(OH)D 浓度四分位数之间(p=0.85 检验假设)或作为连续变量(p=0.89)与 18 岁时疑似和明确精神病体验之间没有关联。在该队列中,只有 29 名受试者在 18 岁时符合精神病障碍标准。基于该样本,母体 25(OH)D 与 18 岁时的精神病障碍之间无显著关联。
在本出生队列中,母体维生素 D 水平与精神病体验风险或精神病障碍无关。